Canada markets closed

Sangamo Therapeutics, Inc. (SGMO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.10-0.35 (-4.14%)
At close: 04:00PM EST
8.10 0.00 (0.00%)
After hours: 06:24PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close8.45
Open8.50
Bid8.00 x 3000
Ask8.35 x 3100
Day's Range8.03 - 8.50
52 Week Range7.81 - 19.43
Volume1,356,130
Avg. Volume1,188,879
Market Cap1.18B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateFeb. 22, 2022 - Feb. 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.67
  • GlobeNewswire

    Organogenesis Appoints Prathyusha Duraibabu to Board of Directors

    CANTON, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced the appointment of Prathyusha Duraibabu to the Company’s Board of Directors, effective November 19, 2021. Ms. Duraibabu will serve as an independent director of the Company and member of the Audit Co

  • Business Wire

    Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

    BRISBANE, Calif., November 09, 2021--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences:

  • Zacks

    Wall Street Analysts Think Sangamo (SGMO) Could Surge 64%: Read This Before Placing a Bet

    The mean of analysts' price targets for Sangamo (SGMO) points to a 64.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.